Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
Source: Risk Management and Healthcare Policy - Category: Health Management Tags: Risk Management and Healthcare Policy Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Health Management | Lung Cancer | Non-Small Cell Lung Cancer